John D. Clemens, David A. Sack, Jeffrey R. Harris, J. Chakraborty et al.
Journal Article ABO Blood Groups and Cholera: New Observations on Specificity of Risk and Modification of Vaccine Efficacy Get access John D. Clemens, John D. Clemens Please address requests for reprints to Dr. John D. Clemens, Center for Vaccine Development, University of Maryland School of Medicin...
Hasan Ashraf, Nur Alam, Christian Rothermundt, Abdullah Brooks et al.
BACKGROUND: Viral hepatitis is a serious global public health problem affecting billions of people globally, and both hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are rapidly spreading in the developing countries including Bangladesh due to the lack of health education, poverty, il...
Tatsuo Kanda, George Lau, Lai Wei, Mitsuhiko Moriyama et al.
In the direct-acting antiviral (DAA) era for hepatitis C virus (HCV) infection, sustained virological response (SVR) is very high, but close attention must be paid to the possible occurrence of hepatocellular carcinoma (HCC) and reactivation of hepatitis B virus (HBV) in patients with co-infection w...
Nicola Coppola, Loredana Alessio, Luciano Gualdieri, Mariantonietta Pisaturo et al.
Screening of undocumented migrants or refugees for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections has been offered free of charge and free from bureaucratic procedures since 2012 at four primary-level clinical centres in Naples and Caserta, Italy. ...
G. M. Kabir Uddin, D. Shoeb, Susannah Solaiman, Richard Marley et al.
The prevalence of hepatitis B and hepatitis C in immigrant communities is unknown. Immigrants from south Asia are common in England and elsewhere, and the burden of viral hepatitis in these communities is unknown. We aimed to determine the prevalence of viral hepatitis in immigrants from south Asia ...
Mamun-Al Mahtab, Salimur Rahman, Md. Fazal Karim, Mobin Khan et al.
BACKGROUND: Hepatitis B virus (HBV) is encountered sporadically the year round in Bangladesh. It results in a wide range of liver diseases, with asymptomatic acute hepatitis at one end to hepatocellular carcinoma (HCC) at the other end of the spectrum. METHODS: All 1018 individuals of different age ...
Rengaswamy Sankaranarayanan, Neerja Bhatla, Patti E. Gravitt, Partha Basu et al.
Although one-third of the world cervical cancer burden is endured in India, Bangladesh, Nepal and Sri Lanka, there are important gaps in our knowledge of the distribution and determinants of the disease in addition to inadequate investments in screening, diagnosis and treatment in these countries. P...
Saad Ahmed Sami, Kay Kay Shain Marma, Shafi Mahmud, Md. Asif Nadim Khan et al.
direct contact with infected individuals or animals. Despite being considered to be less threatening in terms of appearances and the number of infected patients, the high fatality rate of this pathogenic virus is a major concern. Until now, no vaccine has been developed to combat this deadly virus. ...
Suzanne Wait, Emily Kell, Saeed Hamid, David Handojo Muljono et al.
In 2015, the Coalition to Eradicate Viral Hepatitis in Asia Pacific gathered leading hepatitis experts from Bangladesh, India, Indonesia, Malaysia, Pakistan, the Philippines, and Thailand to discuss common challenges to the burden posed by hepatitis B virus (HBV) and hepatitis C virus (HCV), to lear...
Masao Omata, Tatsuo Kanda, Lai Wei, Ming‐Lung Yu et al.
The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on "APASL consensus statements and recommendations for management of hepatitis C" in March 2015 to revise the "APASL consensus statements and management algorithms for hepatitis C virus infection...
Mamun Al Mahtab, Sheikh Mohammad Fazle Akbar, Julio Aguilar, Gerardo Guillén et al.
CONTEXT: Current drugs for chronic hepatitis B therapy have a poor efficacy in terms of post-treatment sustained viral suppression and generate important side effects during and after therapy. Therapeutic vaccination with HBV antigens is an attractive alternative to test. OBJECTIVE: Evaluating the e...
Graham Cooke, Barnaby Flower, Evan B. Cunningham, Alison D. Marshall et al.
The top 20 highest burdened countries (in disability-adjusted life years) account for more than 75% of the global burden of viral hepatitis. An effective response in these 20 countries is crucial if global elimination targets are to be achieved. In this update of the Lancet Gastroenterology & Hepato...
Vishal Batra, Amitava Goswami, Sunil Dadhich, Dinesh Kothari et al.
BACKGROUND: Healthcare workers (HCWs) are at high risk for hepatitis B virus (HBV) infection. The aim of the study was to evaluate HBV immunization status and anti-HBs titer among HCWs. METHODS: AntiHBs titer was prospectively examined in all vaccinated of the 464 HCWs enrolled. A comparison was don...
Emily S. Gurley, Jahangir Hossain, Repon C. Paul, Hossain M. S. Sazzad et al.
BACKGROUND: Hepatitis E virus (HEV) causes outbreaks of jaundice associated with maternal mortality. Four deaths among pregnant women with jaundice occurred in an urban community near Dhaka, Bangladesh, in late 2008 and were reported to authorities in January 2009. We investigated the etiology and r...
Hasan Zaki
Hepatitis B virus (HBV) infection is one of the most prevalent public health problems worldwide, and causes 1 million deaths annually. In Bangladesh, information about prevalence of HBV infection is scarce, and there is no available data on HDV infection. We determined rates of HBsAg and anti-HBc se...